Sign inGet started

Rajavelu Esther

Insider CIK 1903716 · FULC Chief Financial Officer · SPRO See Remarks

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SPRO Spero Therapeutics, Inc. S Sale2026-05-042026-05-0625,240$2.51 $63.4K986,851SEC↗
SPRO Spero Therapeutics, Inc. S Sale2026-02-062026-02-0950,816$2.36 $119.9K1,012,091SEC↗
SPRO Spero Therapeutics, Inc. S Sale2026-02-062026-02-0937,101$2.36 $87.6K1,062,907SEC↗
SPRO Spero Therapeutics, Inc. A Award deriv2026-02-022026-02-04498,000— $0498,000SEC↗
SPRO Spero Therapeutics, Inc. A Award2026-02-022026-02-04249,000— $01,118,450SEC↗
SPRO Spero Therapeutics, Inc. S Sale2026-02-022026-02-0418,442$2.20 $40.6K1,100,008SEC↗
SPRO Spero Therapeutics, Inc. S Sale2025-11-072025-11-1240,270$2.37 $95.4K869,450SEC↗
SPRO Spero Therapeutics, Inc. A Award2025-05-022025-05-06185,000— $0909,720SEC↗
SPRO Spero Therapeutics, Inc. S Sale2025-02-052025-02-0520,689$0.78 $16.1K724,720SEC↗
SPRO Spero Therapeutics, Inc. A Award2025-02-032025-02-05266,139— $0645,409SEC↗
SPRO Spero Therapeutics, Inc. A Award2025-02-032025-02-05100,000— $0745,409SEC↗
SPRO Spero Therapeutics, Inc. S Sale2024-11-082024-11-1217,245$1.30 $22.4K379,270SEC↗
SPRO Spero Therapeutics, Inc. S Sale2024-11-072024-11-1223,351$1.31 $30.6K396,515SEC↗
SPRO Spero Therapeutics, Inc. A Award2024-02-012024-02-05119,866— $0419,866SEC↗
SPRO Spero Therapeutics, Inc. A Award2023-11-132023-11-15300,000— $0300,000SEC↗
FULC Fulcrum Therapeutics, Inc. A Award deriv2023-02-092023-02-13160,000— $0160,000SEC↗
FULC Fulcrum Therapeutics, Inc. A Award deriv2022-01-032022-01-10200,000— $0200,000SEC↗